Browsing: biopharmaceuticals

Editorials ICH-M10 guidance-test-tubes-pipette

In this editorial, the author discusses the progression of the metabolomics field, the growing number of databases that are appearing and new separation techniques such as ion mobility, which are adding a fourth dimension to identification capabilities.

Panel Discussions DJb-y_ZWAAAw_ko

This entry is part 1 of 4 in the series Business of bioanalysis: season 2

In late 2017 Bioanalysis and Bioanalysis Zone organized a panel discussion comprising of experts from leading CROs and pharmaceutical companies to converse about the latest topics in bioanalysis.
In this series of three panel discussions, key opinion leaders from both industries returned to partake in an open dialogue talking through the latest challenges the industry is facing and what changes they would like to see happen in the coming future.

Panel Discussions BZ BOB 3

This entry is part 4 of 4 in the series Business of Bioanalysis

In this final video the Business of bioanalysis panelists discuss the impact of mergers, acquisitions, and organic growth on bioanalytical sciences. The scientific community in which we work goes beyond affiliation, movement of bioanalytical scientists and talent between CRO, pharmaceutical and instrument vendors. The business is robust, while management of corporate culture is critical.

1 2